Discover Great Companies Discover Great Clients
Popularity  2万   |   Followers  1   |   Likes  8 Claim this company

Developing nucleic acid drugs based on RNA interference (RNAi) technol

No.867 Suzhou Popularity Ranking No.138 Kunshan City Jiangsu No.1 Nucleic Acids No.3 He Gan Acids No.3 He Suan Yao Products No.6 Yao Li Yan Jiu No.8 Innovative Drugs Products No.10 Yuan Yan Yao No.14 Innovative Drugs No.14 Pharmaceutical R&D No.18 Biotechnology Pharmaceuticals No.21 Sheng Ming Ke Xue No.22 Biological Products No.33 Biopharmaceuticals 理事长单位 发明专利 高新技术企业 省级高新技术企业 市级创新型中小企业
More

Company Overview

  • Nature: Foreign-funded Enterprise Size: 100-499 employees Founded: 19年
  • Industry: Pharmaceutical/Bioengineering 、 Diversified Business Groups
  • Full name: Suzhou Ribo Life Science Co., Ltd.。

Development Stage

  • Stage: F轮, 3300万美元。
  • Ranking: Ranked #867 in Suzhou by popularity Ranked #1 in Suzhou Nucleic Acids Company by popularity Ranked #3 in Suzhou He Gan Acids Company by popularity Ranked #3 in Suzhou He Suan Yao Products Company by popularity Ranked #6 in Suzhou Yao Li Yan Jiu Company by popularity
  • Honors: 理事长单位 发明专利 According to algorithm
  • Salary: 85.9% of positions earn 10-50K, In 2026 vs last yeardecreased by 11%.。Master's salary: ¥27.0K, Doctorate salary: ¥33.6K.
  • R&D: "Biology/Pharmaceutical/Chemical/Environmental Protection" demand: 44.9%, "Other (R&D and Technical)": 28.2%, "Scientific Research": 26.9%。
  • Recruiting: In 2026 vs 2025grew by 59%. Demand for highly educated talent: Master's: 13, Doctorate: 4.
  • Requirement: Education: 本科 leads with 57.3%. Experience: 5-10年 leads with 46.1%.
  • Region: Distributed across 2 regions, 苏州: 51.7%, 北京: 43.8%, 济南: 4.5%.

About the Company

[Summary] Developing nucleic acid drugs based on RNA interference (RNAi) technol

Founded in 2007, Ribo Life Science focuses on the development of RNA interference (RNAi) technology and the industrialization of small nucleic acid drugs, and is one of the global pioneers in this field. The company has established an independently controllable small nucleic acid drug R&D platform with integrated full-technology-chain capabilities, built a globally integrated small nucleic acid drug development system, and created a rich siRNA drug pipeline through independent innovation, covering multiple diseases including cardiovascular, metabolic, kidney and liver diseases, especially in the field of chronic disease treatment.

With its international independent innovation R&D platform, the company has achieved full-life-cycle technology coverage of small nucleic acid drugs from early research to commercialization, including drug delivery, chemical modification, multi-target design, model-informed drug development, and pharmaceutical development and production. Among them, the company's independently developed liver-targeting RiboGalSTARTM delivery technology has advanced multiple products to Phase II clinical trials, with efficacy and safety well clinically validated. The company has reached a technology-platform-based cooperation with Germany's Boehringer Ingelheim, a highly representative collaboration among Chinese biotechnology companies, fully reflecting the high recognition of Ribo Life Science's R&D platform and scientific research strength by multinational pharmaceutical companies.

With a highly forward-looking global strategic layout, Ribo Life Science has established multiple R&D centers in Beijing and Suzhou, China, as well as in Europe. In the fierce global biopharmaceutical competitive landscape, driven by both a global R&D strategy and an international management team, the company has gathered an international team with extensive multinational pharmaceutical experience to support its sustainable development and global competitiveness, and to drive China's small nucleic acid pharmaceutical industry to the world's forefront.

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Ribo Life Science Financing History (10 rounds)

Manage
F轮
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Amount: 3300万美元
  • Investor: Erik,Selin,Ja...

Ribo Life Science How Fast Is Hiring Growing? (29 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Up 95%
  • 2024: Down 52%
  • 2023: Down 61%
  • 2022: Down 10%
Ribo Life Science Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
Ribo Life Science Campus Recruitment & Advanced Degree Talent Demand
Master's 13 Doctorate 4
Note: How fast is hiring at Suzhou Ribo Life Science Co., Ltd. growing? Ribo Life Science2026: 65 openings (up 59%), 2025: 41 openings (up 95%), 2024: 21 openings (down 52%), 2023: 44 openings (down 61%), 2022: 113 openings (down 10%), 2021: 125 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Ribo Life Science Master's Degree Job Demand Analysis

(More)
How fast is master's hiring at Suzhou Ribo Life Science Co., Ltd. growing? . Ribo Life Science master talent ranking in Suzhou: #110, Ribo Life Science master salary mostly around 10-50K.

Ribo Life Science R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Suzhou Ribo Life Science Co., Ltd.? Based on an analysis of Ribo Life Science's job postings over the past year, "Biology/Pharmaceutical/Chemical/Environmental Protection" demand: 44.9%, "Other (R&D and Technical)": 28.2%, "Scientific Research": 26.9%, "Medical & Health/Beauty & Healthcare": 14.1%, "Mechanical/Instrumentation": 2.6%, "Computer/Network/Technology": 2.6%. For reference only.

Ribo Life Science — What Are the Salaries Like? (78 records)

Manage
Ribo Life Science Salary Overview
salary range: 6K - 50K, 85.9% of roles pay ¥10-50K
Note: salary statistics are based on 78 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Suzhou Ribo Life Science Co., Ltd.?Ribo Life Science85.9% of positions earn 10-50K, Undergraduate salary: ¥。Suzhou salary ranking top 10,生物/制药/化工/环保类 average salary ¥22.2K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of Ribo Life Science

(More)
Are salaries high at Suzhou Ribo Life Science Co., Ltd.? We provide: Researcher, Procurement, Chemistry, Analyst, coe, Synthesis Technician, Trainer, 知识产权, 临床, Legal Counsel, 纯化技术员, Senior Manager, BP, dm, HR, 产权专员, Vice President, 平台负责人, 维修管理, Maintenance. Click to view detailed salary analysis by job.

Ribo Life Science honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Job Category

  • 生物/制药/化工/环保类
    40.4% of total 40.4%
  • 其他(研发和技术类)
    27% of total 27%
  • 科研类
    25.8% of total 25.8%
  • 经营管理类
    23.6% of total 23.6%

Education

  • 本科
    57.3% of total 57.3%
  • 硕士
    31.5% of total 31.5%
  • 博士
    7.9% of total 7.9%
  • 大专
    3.4% of total 3.4%

Experience

  • 5-10年
    46.1% of total 46.1%
  • 3-5年
    25.8% of total 25.8%
  • 1-3年
    18% of total 18%
  • 不限
    10.1% of total 10.1%
View Detailed Analysis

What does Suzhou Ribo Life Science Co., Ltd. require? Who is Ribo Life Science hiring? Ribo Life Science recruitment: 生物/制药/化工/环保类占比最多占40.4%,其次是其他(研发和技术类)占27%. What education can get in at Ribo Life Science? 本科占比最多占57.3%,其次是硕士占31.5%. High education required at Ribo Life Science? 硕士占31.5%,博士占7.9%. Work experience required at Ribo Life Science? 5-10年占比最多占46.1%,其次是3-5年占25.8%. Where are the job locations at Ribo Life Science? 苏州占比最多占51.7%,其次是北京占43.8%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 13,420.311万(元)
Legal Representative: LIANG ZICAI(梁子才)
Date Established:
Credit Code: 913205837965412157
Registered Address: 江苏省昆山市玉山镇元丰路168号

Partners & Suppliers

签署战略合作协议,共同开发核酸药物,提供CDMO服务 Source
供应商 核酸药物CDMO客户
合作开发小核酸药物 Source
合作客户 医药工业-技术开发合作
君实生物与瑞博生物合作开发siRNA药物,瑞博生物提供小核酸技术平台。 Source
合作客户 合作开发/技术引进
为瑞博生物提供小核酸药物的研发和生产CDMO服务 Source
供应商 小核酸药物CDMO
签署战略合作协议,共同开发小核酸药物 Source
供应商 战略合作

People who follow Ribo Life Science also follow

Ribo Life Science Competitors (Similar Companies)

“To develop high-quality biologics that are accessible and affordable f”
“Microbial resource service provider”
“Bringing better treatment options to cancer patients worldwide”
“A renowned enterprise in China's liver disease and anti-tumor fields”
医药 新药研发 CRO 医药CRO
“R&D, production and commercialization of high-quality human vaccines”
“Continuous innovation, safeguarding health”
“A provider of video-centric intelligent IoT solutions and big data ser”
“High-commitment, high-quality macromolecule drug CDMO technical servic”
制药/药业 医药 医药中间体 原料药
“Biotechnology and bioactive materials”
“Committed to the independent R&D, production, and sales of innovative ”
医药 制药/药业 医药原料 非甾体药
生物科技/生物工程 CRO 干细胞 再生医学
“Developer of innovative small-molecule oncology drugs”

Discover Great Companies, Discover Great Clients

苏州公司名录 苏州“Kunshan City”公司名录 苏州“制药/药业”公司名录 苏州“医药”公司名录 苏州“创新药”公司名录 苏州“药物研发”公司名录 苏州“核酸”公司名录 附近的公司

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates